Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Mr Alfonso Luca Pendolino, University College London, United Kingdom

Based on Mr. Alfonso Luca Pendolino’s experience and research, he could be considered a strong candidate for the Best Researcher Award. Here’s why:

Publication profile

Scopus

Education

From October 2021, a part-time PhD student at UCL’s Ear Institute focused on olfactory dysfunction in chronic respiratory diseases. Clinical Fellow at the Royal National Throat, Nose & Ear Hospital, London. Delivered oral presentations at ERS Thessaloniki 2021 on nasal septal perforation repair and the triple-layer technique. Earned a diploma in Otorhinolaryngology from the University of Padova with magna cum laude honors. Actively engaged in various courses, including Balloon Sinuplasty in Guildford and Smell and Taste 11 in Dresden. Member of ENT UK and the British Rhinological Society, with scientific habilitation in Italy. ✨👃📚💼

Experience

From October 2023 to October 2024, the user works as a Senior Clinical Fellow at St George’s University Hospital NHS Foundation Trust in Ear, Nose, and Throat Surgery, focusing on rhinology and anterior skull base procedures. From February 2019 to October 2023, they held a similar role at the Royal National Throat, Nose and Ear Hospital, part of University College London Hospitals. Since October 2019, they have also been pursuing a PhD in the Ear Institute at University College London, focusing on research. Previously, from December 2014 to December 2018, they trained as a resident in Otolaryngology at the University of Padova. 🎓🩺📊

Expertise and Contributions

Mr. Pendolino has extensive clinical and academic experience in Ear, Nose, and Throat (ENT) surgery, particularly in rhinology and anterior skull base procedures. His work spans senior clinical fellowships at prestigious institutions like St. George’s University Hospital and the Royal National Throat, Nose, and Ear Hospital, combined with a PhD research focus on olfactory dysfunction at the University College London (UCL). This academic engagement showcases his commitment to advancing medical science, specifically in rhinology.

Notable Research and Publications

He has contributed significantly to academic research, authoring several impactful papers on topics such as nasal septal perforation repair, cocaine-induced destructive lesions, and smell loss related to COVID-19. His recent publications in high-impact journals such as Diagnostics and Laryngoscope address both clinical outcomes and advanced ENT techniques, demonstrating a broad impact on both scientific understanding and patient care.

Continuous Learning and Development

Throughout his career, Mr. Pendolino has pursued a range of certifications and courses, from endoscopic skull base surgery to rhinoplasty, which highlights his dedication to continual professional development. His involvement in international conferences, including oral communications and workshops, further positions him as a leader in his field.

Research Impact

Although many of his papers have limited citations due to their recent publication, his research has already influenced surgical practices and patient outcomes, especially concerning sinus surgery and chronic respiratory disease management.

conclusion

Mr. Pendolino’s combination of clinical expertise, high-quality research, and ongoing contributions to ENT surgery make him a commendable candidate for the Best Researcher Award.

Publication top notes

Objective and Subjective Outcomes Following Radiofrequency of Inferior Turbinates in Patients with Sleep-Disordered Breathing

The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy

Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year

The role of large cavity sinus surgery in the management of chronic rhinosinusitis in non-steroidal anti-inflammatory drug exacerbated respiratory disease: A single-centre experience and long-term outcomes

Reply to: Letter to the editor regarding “Long-term quality-of-life impairment in patients with more than 1-year COVID-19–related olfactory dysfunction”

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …